Международный журнал нейрореабилитации

Botulinum Toxin A Therapy In Early Post-Stroke Spasticity: Providing A Wider Treatment Avenue

Abstract

Maria Anna Lorrane P Gozum and Raymond L Rosales

The use of Botulinum toxin type A (BoNT) to address spasticity has been established over the years, and recently considered first line treatment in chronic post stroke patients. With its promising results, BoNT is now being combined with early neurorehabilitation to treat post-stroke spasticity in order to address the various neuromuscular and biomechanical impairments, contracture prevention, dystonia, associated reactions and pain. The beneficial effects of BoNT as an adjunct to early stroke rehabilitation, in contrast to customary physical therapy alone, is the case in point of this review, so as to suggest another complementary treatment avenue in rehabilitation care.